跳转至内容
Merck
CN
所有图片(3)

主要文件

查看所有文档

911593

Sigma-Aldrich

NanoFabTx™ 微流体 - 纳米

device kit for synthesis of 100-200 nm nanoparticles and liposomes

别名:

NanoFabTx™ 设备套件, 微流控套件, 纳米制剂, 纳米颗粒, 脂质体

登录查看公司和协议定价
所有图片(3)

About This Item

UNSPSC代码:
12162002
UNSPSC代码:
41121811
NACRES:
NA.23

描述

Microfludic device kit for synthesizing nanparticles

Kit components :

  • Microfluidic chip x 1
  • Tubings and accessories

质量水平

100

应用

advanced drug delivery

相关类别

一般描述

NanoFabTx™ 微流控纳米设备套件是一套即插即用的易用型微流控部件，兼容Dolomite 微流控系统和标准注射泵（未包括）。 该设备套件可结合我们的专用纳米制剂试剂盒使用（请浏览www.sigmaaldrich.com/nanofabtx）生成尺寸100至200nm 的纳米颗粒或脂质体。该设备套件包括全面的操作方案、预装式微流控芯片歧管、管道和必要的配件。

应用

NanoFabTx™ 微流控纳米设备套件要与NanoFabTx™纳米试剂盒（包括909637、918075和907766）一起使用，用于合成封装药物的脂质体纳米颗粒（LNP） 和封装药物的聚合物纳米颗粒进行靶向给药研究。我们的设备套件利用微流控技术实现窄尺寸分散和高批次间一致性，从而简化LNP制剂和聚合物纳米制剂的配制。微流控芯片歧管（chip manifold）化学性质稳定，可以兼容纳米医学中的各种相关溶剂和药物。微流控芯片的几何尺寸和可控制的流速让用户可以实现100至200纳米的目标颗粒直径、均一的形状和结构。我们基于微流控的工具帮助用户轻松调节合成参数，从而帮助精准医学、药物开发和纳米颗粒癌症治疗领域的科研人员实现封装药物的纳米载体的可扩展合成（scalable synthesis ）。

特点和优势

  • 我们的配方科学家开发和测试的基于微流控的分步操作方案
  • 优化纳米颗粒和脂质体中的药物封装和装载效率
  • 从100-200 nm的范围选择最佳纳米颗粒和脂质体尺寸
  • 反应体积小以减少昂贵试剂和药物的浪费

法律信息

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

相关产品

产品编号
说明
价格

911593

NanoFabTx™ 微流体 - 纳米, device kit for synthesis of 100-200 nm nanoparticles and liposomes

911860

NanoFabTx™ microfluidic - micro, device kit for synthesis of 1-5 μm particles

911879

NanoFabTx™ microfluidic - micro, device kit for synthesis of 10-30 μm particles

909637

NanoFabTx™ PLGA-nano, for synthesis of 100 and 200 nm particles

912212

NanoFabTx™ PLGA-micro, for synthesis of 10-30 um particles

912220

NanoFabTx™ PLGA-micro, for synthesis of 1-5 μm particles

920436

NanoFabTx™ PEG-PLA drug formulation screening kit, for synthesis of PEGylated nanoparticles

915408

NanoFabTx™ PEGylated nanoparticle formulation screening kit

917796

NanoFabTx™ PEG-PLGA drug formulation screening kit, for synthesis of PEGylated nanoparticles

918881

NanoFabTx™ PEG-PCL drug formulation screening kit, for synthesis of PEGylated nanoparticles

918075

NanoFabTx™ PLA-nano, for synthesis of 100 and 200 nm particles

从最新的版本中选择一种：

分析证书(COA)

Lot/Batch Number

抱歉，我们目前尚未线上提供该产品的COA。

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow

商品

NanoFabTx™ Drug Delivery Formulations

NanoFabTx™ platform accelerates drug development with ready-to-use formulations and microfluidic devices for particle synthesis.

NanoFabTx™ Nanoparticle and mRNA Liposome Formulation Using the NanoAssemblr®

NanoFabTX drug delivery formulation kits and lipids mixes for mRNA, nucleic acid, and small molecule delivery in lipid nanoparticles, liposomes and polymeric nanoparticles prepared using Precision NanoSystems microfluidic NanoAssemblr

Flash NanoPrecipitation (FNP) – Principles and Applications in Medical Imaging and Drug Delivery

Professor Robert K. Prud’homme introduces flash nanoprecipitation (FNP) for nanoparticle fabrication, which is a scalable, rapid mixing process for nanoparticle formulations.

Microfluidics for Nanoencapsulation of Nucleic Acids

Microfluidic assembly improves polyamine nanoencapsulation of nucleic acids, overcoming challenges like polydispersity and poor reproducibility.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门